Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 38,285 | 32,061 | 26,425 | 16,517 | 7,552 |
| Cost of Goods | 382 | 177 | 136 | 58 | N/A |
| Gross Profit | 37,903 | 31,884 | 26,289 | 16,459 | 7,552 |
| Operating Expenses | 102,968 | 87,691 | 97,710 | 80,946 | 76,952 |
| Operating Income | -64,683 | -55,630 | -71,285 | -64,429 | -69,400 |
| Interest Expense | 27,192 | 27,584 | 28,884 | 28,865 | 37,574 |
| Other Income | 29,782 | 15,905 | 7,864 | -36,606 | 47,795 |
| Pre-tax Income | -62,093 | -67,309 | -92,305 | -129,900 | -59,179 |
| Income Tax | -135 | -35 | 269 | -234 | N/A |
| Net Income Continuous | -61,958 | -67,274 | -92,574 | -129,666 | -59,179 |
| Minority Interests | -14 | -21 | -19 | -20 | -17 |
| Net Income | $-61,944 | $-67,253 | $-92,555 | $-129,646 | $-59,162 |
| EPS Basic Total Ops | -0.06 | -0.07 | -0.10 | -0.15 | -0.07 |
| EPS Basic Continuous Ops | -0.05 | -0.07 | -0.10 | -0.15 | -0.07 |
| EPS Diluted Total Ops | -0.06 | -0.07 | -0.10 | -0.15 | -0.08 |
| EPS Diluted Continuous Ops | -0.05 | -0.07 | -0.10 | -0.15 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.07 | -0.10 | -0.15 | -0.15 |
| EBITDA(a) | $-60,818 | $-51,679 | $-67,353 | $-60,652 | $-60,255 |